Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Establishment of a Patient‐Derived Xenograft Tumor From Hepatitis C–Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy

Hepatology(2020)10.1002/hep.31298Source: DataRank Database

Establishment of a Patient‐Derived Xenograft Tumor From Hepatitis C–Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy is a research paper published in Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.70)OA: greenTopics (56)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Subhayan Sur ORCID,Robert Steele ORCID,Mousumi Khatun ORCID,Tapas Patra ORCID,Nancy J. Phillips

Live enrichment

PubMed:32356575 PMC:PMC7483967 OpenAlex:https://openalex.org/W3021208687

National Institutes of Health

Grant: R01 DK081817

NCI NIH HHS

Grant: R21 CA188472

NIDDK NIH HHS

Grant: R01 DK113645

National Institutes of Health

Grant: 1R21CA188472-01A1

Racial Disparity of microRNA in Hepatitis C Virus Mediated Hepatocellularcarcinoma

National Institutes of Health

Grant: 5R01DK081817-02

Innate Immunity and Hepatitis C Virus Infection

FWCI

1.70

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7483967

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.31298

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31298

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/hep.31298

Fields of Study

Hepatocellular Carcinoma Treatment and PrognosisHepatitis C virus researchLiver physiology and pathology0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAntineoplastic AgentsCarcinoma, HepatocellularDisease Models, AnimalHepatitis C, ChronicHeterograftsHumansImatinib MesylateLiver NeoplasmsMiceNeoplasm TransplantationTreatment OutcomeXenograft Model Antitumor Assays

MeSH Terms

Imatinib MesylateAnimalsAntineoplastic AgentsDisease Models, AnimalCarcinoma, HepatocellularHumansLiver NeoplasmsNeoplasm TransplantationTreatment OutcomeHepatitis C, ChronicXenograft Model Antitumor AssaysMiceHeterografts

Keywords

Hepatocellular carcinomaMedicineCancer researchLiver tumorImatinibHepatitis C virusPathologyCancerInternal medicineImmunologyVirusCarcinoma, HepatocellularLiver NeoplasmsAntineoplastic AgentsHepatitis C, ChronicXenograft Model Antitumor AssaysDisease Models, AnimalMiceTreatment OutcomeImatinib MesylateAnimalsHeterograftsHumansNeoplasm Transplantation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being